Ken Griffin Personalis, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.19 - $6.34 $12,614 - $67,204	-10,600 Reduced 38.55%	16,900 $90,000
Q2 2024 Aug 14, 2024	BUY	$1.17 - $1.65 $31,238 - $44,055	26,700 Added 3337.5%	27,500 $32,000
Q1 2024 May 15, 2024	SELL	$1.15 - $2.19 $114 - $219	-100 Reduced 11.11%	800 $1,000
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.35 $837 - $2,115	900 New	900 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.8 - $3.19 $105,660 - $187,253	-58,700 Reduced 96.71%	2,000 $3,000
Q1 2023 May 15, 2023	BUY	$2.01 - $4.17 $122,006 - $253,119	60,700 New	60,700 $167,000

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $264M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.